GALVmed makes livestock vaccines, medicines and diagnostics accessible and affordable to the millions in developing countries for whom livestock is a lifeline
About GALVmed
Neurocysticercosis, a human disease transmitted from pigs with porcine cysticercosis (PC), causes 30% of human epilepsy cases in the developing world.
The disease is estimated to cause around 5 million human cases and 50,000 human deaths each year.
This is a disease that affects the poor and those who have neurocysticercosis are often stigmatised in their communities.
The first-ever licensed PC vaccine became available in India at the end of 2016 at US $1 for 2 doses to vaccinate a pig.
Product development
GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.
Policy and advocacy
The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.
Newcastle Disease (ND) vaccinators in Mayurbhanj district of Odisha state in India can today look towards bright prospects. The demand for their services has not only spawned new employment opportunities within their locales, but has …
A two-day workshop on Newcastle disease (ND) control in West and Central Africa brought together 38 representatives from the government and private sectors to discuss key challenges and potential interventions in the vaccine delivery and …
July 6th: Today is World Zoonoses Day – a date that has particular relevance in light of the global Brucellosis Vaccine Prize, a US $30 million prize competition inviting vaccine developers to submit proposals for …
